Editorial: Insights into Neurogenetic Research Reviews
-
By
-
Lucia F. Cardo
-
September 14, 2026
Objective:
To review contributions to the Research Topic 'Reviews in neurogenetics' published in Frontiers in Neurology and highlight advancements in diagnosing and treating neurogenetic disorders.
Approach:
- Clinical trials in Charcot-Marie-Tooth Disorders: Nair et al. conducted a retrospective analysis of clinical trials from 1999 to 2022, noting a significant increase in trials focused on procedural and targeted gene therapies, with most trials hosted in academic settings.
- Neuroimaging in PRUNE1 syndrome: Scorrano et al. reviewed the clinical and radiological features of PRUNE1 syndrome, emphasizing the importance of neuroradiological features for diagnosis.
- Genetic blueprints of neurological disorders: Saeed et al. provided a comprehensive review of genetic bases for various neurological disorders and discussed the potential of RNA-based therapeutics and gene therapies.
- Clinical and genetic analysis of cerebrotendinous xanthomatosis: Guoliang et al. investigated a Chinese family with CTX, identifying genetic variants and broadening the understanding of CTX's clinical spectrum.
Key Findings:
- Substantial growth in clinical trials for Charcot-Marie-Tooth disorders, primarily in academic settings.
- Identification of key neuroradiological features in PRUNE1 syndrome that aid in diagnosis.
- Potential of RNA-based therapeutics and gene therapies highlighted in the context of neurological disorders.
- Discovery of specific genetic variants in cerebrotendinous xanthomatosis that enhance diagnostic understanding.
Interpretation:
The editorial emphasizes the need for continued research and application of comparable approaches across various neurogenetic disorders.
Limitations:
- Limited representation of less common neurogenetic disorders in current research.
- Potential biases in the retrospective analysis of clinical trials.
Conclusion:
The editorial calls for further integration of genetic investigations, therapeutic approaches, and neuroimaging to advance understanding and treatment of neurogenetic disorders.
Sources:
Based on findings from:
Editorial: Reviews in neurogenetics
Lucia F. Cardo. Frontiers In Neurology, 2026.
https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1979264/full
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.